Naley wybiera preparaty zatwierdzone przez FDA lub EMA
Pharmacotherapy Synergy: Metformin, GLP-1/GIP Agents, and Lisdexamfetamine Metformin : reduces hepatic gluconeogenesis, improves hepatic insulin sensitivity, modest weight loss, beneficial in PCOS and MASLD risk (Rubio et al., 2020) Tirzepatide (GIP/GLP-1) : significant satiety, delayed gastric emptying, improved insulin secretion in a glucose-dependent manner, glucagon reduction, weight loss, improved A1C/triglycerides/inflammation (Frias et al., 2021) Contraception considerations : incretin agents may delay gastric emptying
Aumento del volume massimo di ossigeno Diminuzione dei livelli di lattato dopo un intenso esercizio fisico, che riduce l'affaticamento muscolare Miglioramento del recupero dopo un intenso esercizio fisico
That time frame depends on both the model and the goal because fat loss and cartilage regeneration are not the same